Quantifying unmet prevention needs among msm in europe through a multi-site bio-behavioural survey
Mirandola, M., Gios, L., Sherriff, N., Marcus, U., Toskin, I., Rosinska, M., Schink, S., Kühlmann-Berenzon, S., Suligoi, B., Folch, C., Nöstlinger, C., Dias, S., Stanekova, D., Klavs, I., Caplinskas, S., Rafila, A., Marin, C., Alexiev, I., Zohrabyan, L., Noori, T., Menel-Lemos, C.
Infographic: HIV and AIDS in Europe 2017
Europe experiences a persistent HIV epidemic, with only little changes in notifications during the last decade in the EU/EEA. One reason for this: an estimated 120 000 Europeans are living with undiagnosed HIV in the EU/EEA, which means that about 1 in 5 (15 %) of those living with HIV are not aware of their status. And it takes around three years from HIV infection to diagnosis.
HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets
Brown, A.E., Hayes, R., Noori, T., Azad, Y., Amato-Gauci, A.J., Pharris, A., Delpech, V.C., The Ecdc Dublin Declaration Monitoring Network
World AIDS Day 2018: Know the epidemic, shape the response
The tools to end new HIV infections and AIDS exist. The knowledge on how to use them is agreed upon. Nevertheless late diagnosis of HIV remains a challenges across the European Union and European Economic Area.
Marking European Testing Week: ECDC issues integrated hepatitis and HIV testing Guidance
To mark European Testing Week from 23 to 30 November 2018, ECDC publishes its new Guidance on integrated viral hepatitis and HIV testing.
Lymphogranuloma venereum (LGV) in men who have sex with men (MSM): A re-emerging problem, Malta, 2018
Donachie, A., Spiteri, G., Barbara, C., Melillo, T., Hadad, R., Farrugia, A.G., Unemo, M., Padovese, V.
Protective measures for humans against avian influenza a(H5N8) outbreaks in 22 European Union/European economic area countries and Israel, 2016–17
Adlhoch, C., Dabrera, G., Penttinen, P., Pebody, R.
The benefits of HIV treatment: undetectable means you do not pass on the virus
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
Monitoring the HIV continuum of care in key populations across Europe and Central Asia
Brown, A., Attawell, K., Hales, D., Rice, B., Pharris, A., Supervie, V., Van Beckhoven, D., Delpech, V., An der Heiden, M., Marcus, U., Maly, M., Noori, T.